HCCO Insider Trading Activity and SEC Form 4 Filings
HCCO insider trading summary
No open-market insider purchases or sales of Healthcare Merger Corp. (HCCO) have been reported on SEC Form 4 in the past 12 months.
Latest HCCO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 30, 2020 | Alyeska Master Fund 3, L.P. | 10% Owner | Buy | $226K (25,000 @ $9.04) |
| Oct 30, 2020 | Alyeska Master Fund, L.P. | 10% Owner | Buy | $225K (24,802 @ $9.09) |
| Oct 30, 2020 | Alyeska Investment Group, L.P. | 10% Owner | Buy | $229K (25,000 @ $9.15) |
| Oct 30, 2020 | Alyeska Master Fund, L.P. | 10% Owner | Buy | $229K (25,000 @ $9.15) |
| Oct 30, 2020 | Alyeska Investment Group, L.P. | 10% Owner | Buy | $2K (198 @ $9.09) |
| Oct 30, 2020 | Alyeska Investment Group, L.P. | 10% Owner | Buy | $227K (25,000 @ $9.09) |
| Oct 30, 2020 | Alyeska Investments, LLC | 10% Owner | Buy | $225K (24,802 @ $9.09) |
| Oct 30, 2020 | Alyeska Master Fund 3, L.P. | 10% Owner | Buy | $2K (198 @ $9.09) |
| Oct 30, 2020 | Alyeska Fund Gp, LLC | 10% Owner | Buy | $225K (24,802 @ $9.09) |
| Oct 30, 2020 | Alyeska Investment Group, LLC | 10% Owner | Buy | $227K (24,801 @ $9.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.